Prof.Dr.rer.nat.
Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, Germany
Bernd Giebel studied biology at the University zu Köln and received his PhD in 1996. 1999 he moved to the Heinrich-Heine-University of Düsseldorf, started to work with human hematopoietic stem and progenitor cells and set up his own group. In 2008 he moved to the University Hospital Essen and continued his studies on human somatic stem cells. In 2009, as a 2nd topic his group started to work with EVs, setting a focus on mesenchymal stem/stromal cell-derived EVs (MSC-EVs). Together with collaboration partners the group demonstrated the therapeutic potential of prepared MSC-EVs in a human GvHD-patient and in different animal models. It is the goal to optimize the MSC-EV production and characterization process to efficiently translate MSC-EVs into the clinics. He is the president of the German Society of Extracellular Vesicles (GSEV), co-chairing the exosome working of the group of the International Society of Gene and Cell Therapy (ISCT) and part of the scientific advisory board of two SME companies, Innovex Therapeutics and EVOX.